2Radin EL,Swann DA,Weisser PA. Separation of a hyaluronate - free lubrication fraction from synovial fluid [J ]. Nature, 1970,228: 377- 378.
3Clarris BJ, Fraser JRE. On the pericellular zone of some mammaliom cells in vitro[J]. Exp Cell Res,1968,49:181- 193.
4MeBbride WH,Bard JB. Hyaluronidase-sensitive halos around adherent cells,Their role in blocking,lymphocyto-mediated cytolysis[J]. J Exp Me, 1979,149:507-515.
5Gaoely CL,Maul LM,Greenwood MA,et al. Invitro studies on the cell-mediated immune response to human brian twnors. Ⅱ . Lewkocyte induced coat of glycosaminogly can increase resistance of glioma cells to cellular immune attack[J]. J Immunol, 1984.133: 3387-3395.
6Clams Bj,Fraser JRE,Rodda SJ. Effect of cell-bound hyaluronic acid on infeetivity of New castle disease virus of human synovial cells in vitro[J]. Ann Rheum Dis, 1974,33: 240- 242.
7Font J, Auberg M. Inaccessibility of certain Ricinus lectin binding sites due to increase in hyaluronic acid during chick embryo development[J]. Differentiation,1983,25:23-26.
8Sakakibara Y,Miura T,Iwata H,et al. Effect of high -molecular-weight Sodium hyaluronate on immobilized rabbit knee[J]. Clin Orthop Res, 1994,299: 282-292.
6Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries [J]. Clin Orthop,1985,(198):43-49.
7Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent [J]. Semin Arthritis Rheum,2002,32(1):10-37.
8Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis [J]. J Rheumatol Suppl,1993,39:3-9.
9Pelletier JP, Martel-pelletier J. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation [J]. J Rheumatol Suppl,1993,39:19-24.
10Nonaka T. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis [J]. J Rheumatol,2000,27(4):997-1004.
